Corvus Pharmaceuticals, Inc. (CRVS) Social Stream
CORVUS PHARMACEUTICALS INC (CRVS) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CRVS.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-12 | 5 | $6 | $3.5 | $5.125 | $2.16 | 137.27% |
| 2021-12-01 | 5 | $8 | $3.5 | $5.7 | $2.16 | 163.89% |
| 2021-12-03 | 5 | $8 | $3.5 | $6.3 | $2.16 | 191.67% |
| 2022-05-11 | 2 | $8 | $6 | $7 | $2.16 | 224.07% |
| 2022-08-09 | 3 | $8 | $4 | $6 | $2.16 | 177.78% |
| 2022-10-07 | 4 | $8 | $2 | $5.333 | $2.16 | 146.9% |
| 2022-11-07 | 3 | $6 | $2 | $3.333 | $2.16 | 54.31% |
| 2022-12-14 | 4 | $6 | $2 | $3.666 | $2.16 | 69.72% |
| 2023-04-05 | 4 | $3.5 | $2 | $2.833 | $2.16 | 31.16% |
| 2023-05-09 | 4 | $4 | $3 | $3.5 | $2.16 | 62.04% |
| 2023-05-29 | 4 | $8 | $3.5 | $4.875 | $2.16 | 125.69% |
| 2023-05-30 | 4 | $10 | $3.5 | $6.375 | $2.16 | 195.14% |
| 2023-08-10 | 4 | $12 | $3.5 | $6.875 | $2.16 | 218.29% |
| 2023-08-18 | 5 | $12 | $3.5 | $6.9 | $2.16 | 219.44% |
| 2023-11-08 | 5 | $12 | $3.5 | $7.1 | $2.16 | 228.7% |
The Trend in the Analyst Price Target
Over the past 32 months, CRVS's average price target has gone down $2.15.
Over the past 32 weeks, CRVS's average upside potential has been 229.46%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-04-05 | 4 | 3.5 | 2.0 | 2.833 | 0.998 | 183.87% |
| 2023-05-09 | 4 | 4.0 | 3.0 | 3.500 | 1.295 | 170.27% |
| 2023-05-30 | 4 | 10.0 | 3.5 | 6.375 | 3.090 | 106.31% |
| 2023-09-07 | 5 | 12.0 | 3.5 | 7.100 | 1.640 | 332.93% |
| 2023-11-08 | 5 | 12.0 | 3.5 | 7.100 | 1.600 | 343.75% |
CRVS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.4 | 4 | 0 | 1 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
Over the past 30 months, CRVS's average broker recommendation rating improved by 0.93.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how CORVUS PHARMACEUTICALS INC fares relative to all US stocks, note that its average analyst price target is greater than 135.39% of that group.
- CORVUS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 364.85% of all US stocks.
- CORVUS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1824.44% of stocks in the small market cap category.
- In the context of stocks in the small market cap category, CORVUS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1692.21% of them.
In the Pharmaceutical Products industry, SNDX, MRKR, and RLMD are the three stocks most similar to CORVUS PHARMACEUTICALS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is CRVS a Buy, Hold or Sell? See the POWR Ratings now!